In vivo application of chitosan to improve bioavailability of cyanocobalamin, a form of vitamin B12, following intraintestinal administration in rats

Yuko Goto, Ayumi Masuda, Tetsuya Aiba

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The effect of chitosan on the intestinal absorption of cyanocobalamin (VB12), a stable form of vitamin B12, was investigated in vivo in rats, with the aim of improving the oral bioavailability of VB12 for anemia treatment in patients with gastrectomy. The bioavailability was evaluated based on the plasma concentration profile of VB12 following intraintestinal administration of the VB12 solution containing chitosan at various concentrations. The bioavailability of VB12 was 0.6 ± 0.2% when the chitosan-free VB12 solution was administered, while it increased to 10.5 ± 3.3% when chitosan was dissolved in the VB12 solution at a concentration of 1%. The bioavailability of VB12 increases with the chitosan concentration, in which chitosan seems to augment the amount of VB12 absorbed without affecting the absorption rate constant of VB12. It was also shown that the bioavailability of VB12 does not increase further when the degree of chitosan deacetylation is increased from 83 to 100% by substitutively employing the fully deacetylated chitosan. These findings suggest that the oral administration of VB12 with readily available chitosan may be a practical approach for anemia treatment in patients with gastrectomy.

Original languageEnglish
Pages (from-to)250-255
Number of pages6
JournalInternational Journal of Pharmaceutics
Volume483
Issue number1-2
DOIs
Publication statusPublished - Apr 15 2015

Fingerprint

Chitosan
Vitamin B 12
Biological Availability
Gastrectomy
Anemia
Intestinal Absorption
Oral Administration
Therapeutics

Keywords

  • Anemia
  • Bioavailability
  • Chitosan
  • Cyanocobalamin
  • Gastrectomy
  • Vitamin B

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

@article{c5008c96ebc548a2b85f52bdda89654b,
title = "In vivo application of chitosan to improve bioavailability of cyanocobalamin, a form of vitamin B12, following intraintestinal administration in rats",
abstract = "The effect of chitosan on the intestinal absorption of cyanocobalamin (VB12), a stable form of vitamin B12, was investigated in vivo in rats, with the aim of improving the oral bioavailability of VB12 for anemia treatment in patients with gastrectomy. The bioavailability was evaluated based on the plasma concentration profile of VB12 following intraintestinal administration of the VB12 solution containing chitosan at various concentrations. The bioavailability of VB12 was 0.6 ± 0.2{\%} when the chitosan-free VB12 solution was administered, while it increased to 10.5 ± 3.3{\%} when chitosan was dissolved in the VB12 solution at a concentration of 1{\%}. The bioavailability of VB12 increases with the chitosan concentration, in which chitosan seems to augment the amount of VB12 absorbed without affecting the absorption rate constant of VB12. It was also shown that the bioavailability of VB12 does not increase further when the degree of chitosan deacetylation is increased from 83 to 100{\%} by substitutively employing the fully deacetylated chitosan. These findings suggest that the oral administration of VB12 with readily available chitosan may be a practical approach for anemia treatment in patients with gastrectomy.",
keywords = "Anemia, Bioavailability, Chitosan, Cyanocobalamin, Gastrectomy, Vitamin B",
author = "Yuko Goto and Ayumi Masuda and Tetsuya Aiba",
year = "2015",
month = "4",
day = "15",
doi = "10.1016/j.ijpharm.2015.02.016",
language = "English",
volume = "483",
pages = "250--255",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - In vivo application of chitosan to improve bioavailability of cyanocobalamin, a form of vitamin B12, following intraintestinal administration in rats

AU - Goto, Yuko

AU - Masuda, Ayumi

AU - Aiba, Tetsuya

PY - 2015/4/15

Y1 - 2015/4/15

N2 - The effect of chitosan on the intestinal absorption of cyanocobalamin (VB12), a stable form of vitamin B12, was investigated in vivo in rats, with the aim of improving the oral bioavailability of VB12 for anemia treatment in patients with gastrectomy. The bioavailability was evaluated based on the plasma concentration profile of VB12 following intraintestinal administration of the VB12 solution containing chitosan at various concentrations. The bioavailability of VB12 was 0.6 ± 0.2% when the chitosan-free VB12 solution was administered, while it increased to 10.5 ± 3.3% when chitosan was dissolved in the VB12 solution at a concentration of 1%. The bioavailability of VB12 increases with the chitosan concentration, in which chitosan seems to augment the amount of VB12 absorbed without affecting the absorption rate constant of VB12. It was also shown that the bioavailability of VB12 does not increase further when the degree of chitosan deacetylation is increased from 83 to 100% by substitutively employing the fully deacetylated chitosan. These findings suggest that the oral administration of VB12 with readily available chitosan may be a practical approach for anemia treatment in patients with gastrectomy.

AB - The effect of chitosan on the intestinal absorption of cyanocobalamin (VB12), a stable form of vitamin B12, was investigated in vivo in rats, with the aim of improving the oral bioavailability of VB12 for anemia treatment in patients with gastrectomy. The bioavailability was evaluated based on the plasma concentration profile of VB12 following intraintestinal administration of the VB12 solution containing chitosan at various concentrations. The bioavailability of VB12 was 0.6 ± 0.2% when the chitosan-free VB12 solution was administered, while it increased to 10.5 ± 3.3% when chitosan was dissolved in the VB12 solution at a concentration of 1%. The bioavailability of VB12 increases with the chitosan concentration, in which chitosan seems to augment the amount of VB12 absorbed without affecting the absorption rate constant of VB12. It was also shown that the bioavailability of VB12 does not increase further when the degree of chitosan deacetylation is increased from 83 to 100% by substitutively employing the fully deacetylated chitosan. These findings suggest that the oral administration of VB12 with readily available chitosan may be a practical approach for anemia treatment in patients with gastrectomy.

KW - Anemia

KW - Bioavailability

KW - Chitosan

KW - Cyanocobalamin

KW - Gastrectomy

KW - Vitamin B

UR - http://www.scopus.com/inward/record.url?scp=84923287575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923287575&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2015.02.016

DO - 10.1016/j.ijpharm.2015.02.016

M3 - Article

VL - 483

SP - 250

EP - 255

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -